XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Feb. 28, 2025
Feb. 29, 2024
Consolidated Statements of Operations and Comprehensive Loss    
Revenues (Note 16) $ 10,889 $ 153
Expenses :    
Research and development (Note 17) 6,864 11,379
General and administrative (Note 18) 9,228 9,988
Impairment of equipment (Note 6) 8,460 0
Depreciation and amortization (Notes 6 and 7) 524 535
Total expenses 25,076 21,902
Other loss (income) :    
Loss on equity accounted investment (Note 11) 687 0
Interest and other financial expenses (income) (Note 22) 618 (41)
Interest income 238 558
Foreign exchange gain (197) (63)
Total other loss (income) 870 (662)
Net loss (15,057) (21,087)
Foreign currency translation adjustment (70) 71
Comprehensive loss $ (15,127) $ (21,016)
Net loss per share    
Basic and diluted $ (0.32) $ (0.44)
Weighted average common shares outstanding    
Basic and diluted 47,587,038 47,522,483